Neutrophil specific granule deficiency (SGD) is a congenital disorder associated with an impaired inflammatory response and a deficiency of several granule proteins. The underlying abnormality causing the deficiencies is unknown. We examined mRNA transcription and protein synthesis of two neutrophil granule proteins, lactoferrin and myeloperoxidase in SGD. Metabolically labeled SGD nucleated marrow cells produced normal amounts of myeloperoxidase, but there was no detectable synthesis of lactoferrin. Transcripts of the expected size for lactoferrin were detectable in the nucleated marrow cells of two SGD patients, but were markedly diminished in abundance when compared with normal nucleated marrow cell RNA. Because lactoferrin is secreted by the glandular epithelia of several tissues, we also assessed lactoferrin in the nasal secretions of one SGD patient by ELISA and immunoblotting. Nasal secretory lactoferrin was the same molecular weight as neutrophil lactoferrin and was secreted in normal amounts. From these data, we conclude that lactoferrin deficiency in SGD neutrophils is tissue specific and is secondary to an abnormality of RNA production. We speculate that the deficiency of several granule proteins is due to a common defect in regulation of transcription that is responsible for the abnormal myeloid differentiation seen in SGD patients.
Introduction
Neutrophil specific granule deficiency (SGD)' is a rare congenital disorder that is characterized by recurrent infections of skin and deep tissues with a variety of bacterial and fungal pathogens without any increased propensity for viral infection (1) . Morphological examination of neutrophils from these patients reveals absent specific or secondary granules on Wright's stain and multiple nuclear abnormalities including blebs, clefts, and bilobed nuclei. In vitro functional disturbances of receptor upregulation, chemotaxis, bactericidal activity, and disaggregation have also been described in SGD neutrophils (2) .
After subcellular fractionation of the granule components of SGD neutrophils on a sucrose gradient, the primary granule fraction is seen as a single broad band that is less dense than normal and the band of the expected density for specific granules is absent (3) (4) (5) . These abnormal banding patterns are associated with the absence or deficiency of a subset of neutrophil secretory proteins that may not be limited to those usually found in specific granules such as lactoferrin and vitamin B-12-binding protein. Other granule proteins, such as the primary granule protein, defensin (6) , and the tertiary granule protein, gelatinase (2, 7) are also deficient. However, not all neutrophil granule proteins are affected and some, such as myeloperoxidase, are present in normal amounts in these patients. The molecular defect responsible for the abnormalities described in SGD neutrophils has not been defined. Because the deficiencies seen in SGD neutrophils involve several secretory proteins from different granule compartments, it is likely that the primary defect is one of regulation of production of these proteins, rather than a mutation of each gene coding for a deficient protein.
We studied production of one deficient granule protein, lactoferrin, in both myeloid and nonmyeloid tissues to begin to define the molecular basis of SGD. Our results demonstrate that there is a myeloid cell-specific defect in synthesis of lactoferrin at the transcriptional level. These data support our hypothesis that the granule protein deficiencies in SGD may represent an abnormality of regulation of protein production and are not secondary to mutations in multiple genes.
Methods
Bone marrow aspirates. Informed consent according to approved protocols was obtained from all patients from whom tissue specimens were obtained. Bone marrow aspirates collected in heparin were obtained from the posterior iliac crests of two patients with SGD who have been described previously (8, 9) and two healthy individuals. Differential cell counts on Wright-Giemsa-stained slides were as follows: Patient M.F., promyelocytes 4%, myelocytes/metamyelocytes 57%, segmented neutrophils/bands 15%, lymphocytes 1%, plasma cells 1%, and erythrocytic elements 22%. Patient M.S., promyelocytes 0%, myelocytes/metamyelocytes 40%, segmented neutrophils/bands 9%, lymphocytes 21%, plasma cells 3%, and erythrocytic elements 27%. Normal individual 1, promyelocytes 0%, myelocytes/metamyelocytes 37%, segmented neutrophils/bands 18%, lymphocytes 15%, and erythrocytic elements 30%. Normal individual 2, promyelocytes 1%, myelocytes/metamyelocytes 20%, segmented neutrophils 31%, eosinophils 3%, lymphocytes 24%, and erythrocytic elements 21%. Nucleated marrow cells were isolated by dextran sedimentation followed by hypotonic lysis of erythrocytes. A decrease in segmented neutrophils and bands relative to earlier myeloid precursors is noted in patient M.S., and is probably due to ongoing chronic infection in this patient.
Northern blot analysis. Total cellular RNA was prepared from nucleated marrow cells isolated as above by the method of Chirgwin (10) 514 or by centrifugation through a cesium chloride gradient after lysis in guanidinium isothiocyanate (Fluka Chemical Corp., Ronkonkoma, NY).
Peripheral blood leukocytes were obtained from a patient with chronic myelogenous leukemia via leukapheresis. Granulocyte precursors were isolated with the monocyte layer by Ficoll-Hypaque centrifugation. Differential cell count from a Wright-Giemsa-stained slide of the cell layer containing monocytes and myeloid precursors was as follows: myeloblasts 8%, myelocytes/metamyelocytes 38%, bands 5%, neutrophils 1%, monocytes 20%, and lymphocytes 28%. Cells were lysed in guanidinium isothiocyanate and centrifuged through a cesium chloride gradient to isolate total cellular RNA.
Uninduced HL-60 cells, a human promyelocytic cell line (I 1), were harvested from culture in RPMI and 10% FCS and total cellular RNA was prepared as described above. Fresh nasal turbinate tissue from patients undergoing therapeutic turbinectomy was homogenized in guanidinium isothiocyanate and particulate matter was removed with low speed centrifugation. Supernatants were spun through a cesuim chloride gradient to isolate RNA.
RNA samples were electrophoresed through 1.8% agarose-formaldehyde gels and blotted onto a membrane (Nytran; Schleicher & Schuell, Keene, NH) overnight in 20X SSC (I X SSC = 150 mM NaCl, 15 mM Na citrate, pH 7.0). The blots were hybridized in 50% formamide, 5X SSPE (I X SSPE = 180 mM NaCl, 10mM NaPO4 (pH 7.7), 1 (14) and immunoprecipitated with Pansorbin. These reactions were also carried out in the presence of excess amounts of exogenously added pure lactoferrin or myeloperoxidase for competitive binding as appropriate. Samples were mixed with 6% SDS sample buffer and analyzed on a 10% acrylamide gel followed by staining with 0.05% Coomassie brilliant blue and autoradiography.
Nasal provocation and ELISA. Samples of nasal secretions were obtained from SGD patient M.S. on two occasions. On the first occasion, only an unstimulated unilateral nasal lavage was performed. On the second occasion, bilateral baseline collections were obtained first, and then an oral gustatory challenge was performed in both the patient and a normal individual. Subjects were seated in an upright position and soft 8F rubber catheters were atraumatically inserted along the floors of one or both nasal cavities to collect nasal secretions and lavages. Nasal saline was delivered to the nose from a hand-held nebulizer bottle and collected by suction through the catheters. Each nasal cavity was lavaged with a 4-ml saline prewash, and then subjects were asked to ingest slowly one or two hot chili peppers to stimulate nasal glandular secretion. After this 10-min oral challenge, the nasal cavities were again lavaged with 4 ml of saline and the fluid collected was assayed for total protein and lactoferrin.
Total protein was measured by the Lowry method using BSA as the standard (15) . Lactoferrin was measured by a direct, noncompetitive ELISA. Microtiter plates were coated with rabbit antihuman lactoferrin (Dako Corp., Santa Barbara, CA) and then blocked with 1% goat serum diluted in a phosphate buffer (16) . Unknown samples or lactoferrin standards were then added, and this was followed by the addition of a rabbit antihuman lactoferrin-horseradish peroxidase conjugate (Cappel Laboratories-Worthington Biochemicals). The plates were developed with a peroxidase substrate (o-phenylenediamine dihydrochloride) and read at 490 nm. The assay sensitivity is 1 ng/ml.
SDS (Fig. 1, lanes A and B) . This pattern is identical to that previously reported for metabolically labeled lactoferrin from normal nucleated marrow cells (19 1, lanes C and D). Antimyeloperoxidase precipitated an identical set of myeloperoxidase-specific bands from patient M.S. nucleated marrow cells (Fig. 2, lanes C and D) . Some additional non-specific bands are seen with patient M.S. nucleated marrow cells that are not seen with normal nucleated marrow cells. The pattern of metabolically labeled myeloperoxidasespecific peptides precipitated by antimyeloperoxidase from normal nucleated marrow cells and patient M.S. nucleated marrow cells in this study is very similar to that previously reported with normal nucleated marrow cells (20) (Fig. 3 A, lane A) , whereas abundant myeloperoxidase mRNA is detected (Fig. 3 B, lane A) as expected for a promyelocytic cell line. Lactoferrin mRNA is easily detected in RNA isolated from chronic myelogenous leukemia peripheral blood cells (predominantly myelocytes/metamyelocytes) ( Fig. 3 A, lane B) . Myeloperoxidase mRNA transcripts are also present in these leukemia cells (Fig. 3 B, lane B) . Patient M.S. nucleated marrow cells contain only a trace amount of lactoferrin mRNA (Fig. 3 A, lane C) when compared with that present in normal nucleated marrow cells (Fig. 3 A, lane D) . These lactoferrin transcripts, though markedly deficient in amount, are the same size as that seen in normal marrow. In contrast, patient M.S. nucleated marrow cells contain abundant myeloperoxidase mRNA (Fig. 3 B, lane C) in an amount that is actually greater than that in the normal nucleated marrow cells examined in this experiment (Fig. 3 B, lane D) .
Northern blots of nucleated marrow cell RNA obtained from a second patient with SGD, M.F., which have been probed with lactoferrin cDNA or myeloperoxidase cDNA are Fig. 3 . Lactoferrin in nasal secretions. To determine whether the neutrophil lactoferrin deficiency in SGD represented an abnormality specific to myeloid cells, we evaluated lactoferrin in secretions from a patient with SGD. Baseline nasal secretions and secretions collected after gustatory provocation to stimulate the nasal serous glands were obtained from SGD patient, M.S., and from a normal individual (Table I ). The amount of nasal lactoferrin secreted by M.S., as measured by percent of total protein, was at normal or greater than normal levels both before and after gustatory challenge.
Lactoferrin was detected after immunoblotting with antilactoferrin antisera in aliquots of nasal secretions and peripheral blood neutrophils from M.S. and a normal individual (Fig.  5) (Fig. 6 ). Transcripts detected in nasal tur- were not performed because of limited amounts of bone marrow obtainable from these patients. The presence of small amounts of lactoferrin transcripts in SGD nucleated marrow cells may result from inappropriate regulation of transcription by cis elements or trans-acting factors, abnormal nuclear processing of mRNAs and/or failure of the lactoferrin mRNA to be transported to the cytoplasm. Because we felt that our data supported our hypothesis that the deficiency of lactoferrin in SGD patients was secondary to an abnormality at the transcriptional level in myeloid cells, we examined lactoferrin production in other tissues. One SGD patient, unrelated to either of the two patients we have studied, has been previously reported to have normal lacrimal fluid lactoferrin (22). We evaluated one of our patients for lactoferrin secretion in nonmyeloid tissues.
Lactoferrin is secreted in a variety of exocrine fluids including lacrimal, nasal, parotid, and salivary gland secretions, breast milk, pancreatic juice, and semen. Recent localization of the human lactoferrin gene to chromosome 3 (23) substantiated previous evidence (24, 25) that lactoferrin protein present in normal neutrophils and lactoferrin secreted by the glandular epithelia of the various tissues listed above is the product of a single gene. Because of ease of accessibility, we chose to examine nasal secretions in one SGD patient for the presence of lactoferrin protein. As measured by ELISA, lactoferrin content in the nasal secretions of our SGD patient, M.S., was at normal levels after oral gustatory challenge. On immunoblot, nasal lactoferrin protein is indistinguishable from the lactoferrin found in normal peripheral blood neutrophils. Lactoferrin transcripts detected in normal nasal turbinate tissue, which has abundant nasal secretory glands, were of the same size as myeloid cell transcripts, thereby providing more evidence that lactoferrin secreted by different tissues is the product of a single gene. Limited Southern blotting experiments probing normal genomic DNA from SGD patients with the same lactoferrin cDNA probe described above did not reveal any differences in restriction fragment pattern between normal and SGD DNA. From these studies we conclude that the SGD patients have a lactoferrin gene with an intact protein coding sequence that is normally expressed in a nonmyeloid tissue.
The defect in expression of the lactoferrin gene in SGD is tissue specific and is associated with normal levels of lactoferrin in nasal secretions in our patient M.S. (and also in this patient's lacrimal, parotid, and submandibular gland secretions; Raphael, G. D., unpublished observations). In myeloid tissues, the defect in expression of this protein is accompanied by a deficiency of mRNA transcripts, suggesting that regulation of protein synthesis in these cells is at the level of mRNA production. Because lactoferrin deficiency in SGD is associated with deficiency of several other granule proteins, we postulate that it represents a stage-specific failure of normal myeloid maturation. It is possible that an abnormality in regulation oftranscription ofthe lactoferrin gene may extend to the other affected proteins and these affected secretory proteins may represent a cassette ofgenes whose expression is regulated coordinately during the appropriate stage of maturation. Understanding the underlying defect in SGD may provide important insights into regulation of myeloid maturation.
